Drug manufacturers often pit their products against competing drugs, but these head-to-head trials may be biased in design and interpretation. For example, studies on antipsychotic drugs often show that the company funding the study has the best drug. These studies also fail to answer questions that doctors need answered before prescribing medications for patients. Shankar Vedantam, The Washington Post 04/12/2006 Read Article: The Washington Post
Wednesday, April 12, 2006
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment